Bill
HB 2218
Concerning access to medical care in workers' compensation.
2025-2026 Regular Session
Introduced by Peter Abbarno and 18 co-sponsors
Allows FDA-approved crystalline polymorph psilocybin to be scheduled as Schedule IV in Kansas after FDA approval and state certification.
Referred to Appropriations.